Group 1 - Shenzhen Tongchuang Weiye Asset Management Co., Ltd. reduced its stake in Runmind Technology-B (02297) by 13 million shares at a price of HKD 0.3448 per share, totaling HKD 4.4824 million [1] - After the reduction, the latest shareholding number is 67.921 million shares, representing a holding percentage of 4.85% [1] - The transaction involved other related parties: Shenzhen Tongchuang Weiye Venture Capital Co., Ltd. and Huang Li [1]

Group 1 - Shenzhen Tongchuang Weiye Asset Management Co., Ltd. reduced its holdings in Runmind-B (02297) by 13 million shares at a price of HKD 0.3448 per share, totaling HKD 4.4824 million [1] - After the reduction, the latest number of shares held is 67.921 million, representing a holding percentage of 4.85% [1] - The transaction involved other related parties: Shenzhen Tongchuang Weiye Venture Capital Co., Ltd. and Huang Li [1]

Core Insights - Recent shareholder equity disclosures were made by several companies including Heptagon Pharmaceuticals-B, Ligao Holdings, Runmed-B, Aigo Group, and Hengxin Holdings on August 18, 2025 [1] Shareholder Changes - Heptagon Pharmaceuticals-B (02142): Golden Sage reduced its holdings from 62.985 million shares to 41.985 million shares, now holding 4.95% [2] - Ligao Holdings (08472): He Hanyu decreased its holdings from 9.034 million shares to 5.684 million shares, now holding 4.93% [2] - Runmed-B (02297): Huang Li reduced its holdings from 80.921 million shares to 67.921 million shares, now holding 4.85% [2] - Aigo Group (00328): Yu Jianchu acquired 5.746 million shares, now holding 5.02% [2] - Hengxin Holdings (01920): Ye Mingshen completely divested from 195 million shares, now holding 0% [2]

智通财经APP获悉，财讯传媒(00205)、立高控股(08472)、润迈德-B(02297)于2025年8月11日进行了最新 股东权益披露。 备注：持股数变动有可能因供股、合股、拆股等情况引起，请注意对照实际情况进行辨别。 | 股票名称 | 机构名称 | 性质 | 变动前持股 | 变动后持股 | 持股比 | | --- | --- | --- | --- | --- | --- | | 财讯传媒(00205) | YONG RONG (HK) ASSET MANAGEMENT | 好仓 | 1.37 亿股 | 1.97 亿股 | 17.84%(最新) 18.60%(前次) | | | LIMITED | | | | | | 立高控股(08472) | 叶永春 | 好仓 | 1011.45 万股 | 561.45 万股 | 4.87%(最新) 8.78%(前次) | | 润迈德-B(02297) | 深圳市同创伟业创业 | 好仓 | 9602.50 万股 | 8092.10 万股 | 5.77%(最新) | | | 投资有限公司 | | | | 6.85%(前次) | | 润迈德-B(02297) | 黄荔 | ...

香港联交所最新资料显示，8月1日，吕永辉减持润迈德-B(02297)79.5万股，每股作价0.3711港元，总金 额约为29.50万港元。减持后最新持股数目为3129.2万股，最新持股比例为2.23%。 ...

香港联交所最新资料显示，8月1日，吕永辉减持润迈德-B(02297)79.5万股，每股作价0.3711港元，总金 额约为29.50万港元。减持后最新持股数目为3129.2万股，最新持股比例为2.23%。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 潤邁德醫療有限公司 呈交日期: 2025年8月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02297 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | 本月底法定/註冊股本總額： ...

Group 1 - The latest shareholder equity disclosures for Eagle Beauty (02368), Runmed-B (02297), and New Reach Holdings (08471) were made on July 31, 2025 [1] Group 2 - Eagle Beauty (02368) saw a slight increase in holdings from 92.568 million shares to 92.608 million shares, maintaining a holding percentage of 16.13% [2] - Runmed-B (02297) experienced a decrease in holdings from 99.025 million shares to 96.025 million shares, with the latest holding percentage at 6.85% compared to 7.07% previously [2] - New Reach Holdings (08471) had significant changes, with one shareholder reducing holdings from 114 million shares to 4.02 million shares, resulting in a holding percentage of 0%, down from 9.30% [2] - Another shareholder in New Reach Holdings increased holdings from 44.77 million shares to 155 million shares, achieving a holding percentage of 12.62%, up from 0.03% [2]

Company Overview - Runmed Medical Co., Ltd. was founded in 2014 and is recognized as a national high-tech enterprise [3] - The company aims to become a global leader in vascular interventional surgical robots, focusing on core products such as the caFFR system, caIMR system, and FlashBot vascular interventional surgical robot [3] - Runmed Medical is committed to innovation and has established a global network for R&D, production, sales, and service [3] Financial Performance - As of December 31, 2024, Runmed-B reported total revenue of 39.824 million yuan, a decrease of 45.61% year-on-year [1] - The company recorded a net profit attributable to shareholders of -113 million yuan, an increase of 2.02% year-on-year [1] - The gross profit margin stood at 59.93%, with a debt-to-asset ratio of 11.48% [1] Market Position and Valuation - Currently, there are no institutional investment ratings for Runmed-B [2] - The average price-to-earnings (P/E) ratio for the healthcare equipment and services industry is -2.24 times, with a median of 1.4 times [2] - Runmed-B has a P/E ratio of -4.23 times, ranking 93rd in the industry [2] Strategic Partnerships and Innovations - The company collaborates with top medical centers and experts both domestically and internationally to build a comprehensive patent system [3] - Runmed Medical has signed strategic cooperation agreements with several leading medical device distribution service platforms in China [3] - The company aims to enhance clinical value through advancements in medical imaging algorithms, fluid dynamics analysis, high-performance mechanical design, and high-end interventional consumables [3]

Summary of Key Points Core Viewpoint - The latest shareholder equity disclosures for several companies, including OKURA HOLDINGS, Sheng Tong Technology, Runmai De-B, Xin Feng Group, and China Merchants China Fund, were made on July 30, 2025, indicating significant changes in shareholding structures and ownership percentages. Group 1: OKURA HOLDINGS (01655) - Ichikura Limited increased its holdings from 72 million shares to 375 million shares, raising its ownership percentage from 12.00% to 62.50% [2][3] - Other entities such as Schädler Claude and Karmad AG also reported similar increases in their holdings, confirming a substantial consolidation of ownership [3] Group 2: Sheng Tong Technology (N23040) - Yang Xiaoyuan reduced his holdings from 138,000 shares to 127,500 shares, resulting in a decrease in ownership percentage from 0.48% to 0.44% [2] Group 3: Runmai De-B (02297) - Huang Li reduced his holdings from 111 million shares to 99.025 million shares, leading to a decrease in ownership percentage from 7.95% to 7.07% [2] - Multiple entities, including Shenzhen Futian Tongchuang Weiye and others, also reported reductions in their holdings, indicating a trend of divestment [2] Group 4: Xin Feng Group (01223) - Ke Qinghui and Huang Lining both reduced their holdings from 470 million shares to 424 million shares, with ownership percentages dropping from 15.80% to 14.26% [2] Group 5: China Merchants China Fund (00133) - Various entities under China Merchants China Fund reported complete divestment from their holdings, with previous ownership percentages ranging from 8.25% to 9.26% [2][3] - The fund's significant reduction in holdings indicates a strategic shift or reallocation of investment focus [3]